Hematología y Hemoterapia

Resultados: 387
Tipo Título / Nombre Autor(es) Año
Concentración de hemoglobina reticulocitaria y ferroterapia en la ERC Deira J, García de la Vega C, Davín E, Arcos MJ 2021
Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial Jiménez-Cortegana C, Palazón-Carrión N, Martín García-Sancho A, Nogales-Fernández E, Carnicero-González F, Ríos-Herranz E , et al 2021
The mutational landscape of acute myeloid leukaemia predicts responses and outcomes in elderly patients from the PETHEMA-FLUGAZA phase 3 clinical trial Ayala R, Rapado I, Onecha E, Martínez-Cuadrón D, Carreño-Tarragona G, Bergua JM, et al 2021
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients Martínez Sánchez MP, Megías-Vericat JE, Rodríguez-Veiga R, Vives S, Bergua JM, Torrent A, et al 2021
Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study Rodríguez-Arbolí E, Martínez-Cuadrón D, Rodríguez-Veiga R, Carrillo-Cruz E, Gil-Cortés C..., Bergua JM, et al 2021
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients Lozano ML, Mingot-Castellano ME, Perera MM, Jarque I, Campos-Álvarez RM..., Bermejo N, et al 2021
A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia Vives S, Martínez-Cuadrón D, Bergua Burgues J, Algarra L, Tormo M, Martínez-Sánchez MP, et al 2021
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma Nowakowski GS, Chiappella A, Gascoyne RD, Scott DW, Zhang Q..., Bergua JM, et al 2021
Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial Simoes C, Paiva B, Martínez-Cuadrón D, Bergua JM, Vives S, Algarra L, et al 2021
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study Muñoz-González JI, Álvarez-Twose I, Jara-Acevedo M..., Bañas MH, et al. 2021